Graham Capital Management, L.P. Krystal Biotech, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 2,379 shares of KRYS stock, worth $445,396. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,379Holding current value
$445,396% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
287Shares Held
24.9MCall Options Held
270KPut Options Held
177K-
Black Rock Inc. New York, NY3.95MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$534 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$456 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$250 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$191 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.8B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...